Voltage | 100-240 VAC |
Frequency | 50-60 Hz |
Current | Single-phase circuit 15 A |
Temperature | 18°C – 27°C / 64.4°F – 80.6°F |
Humidity | 20% to 80% |
Altitude | Up to 2,000 m (6,562 ft) |
Noise metrics | < 67 dB |
Specimen collection type | BD SurePath™ Liquid-based Pap Test Vials BD Molecular Aliquot Tubes BD Onclarity™ HPV Liquid-based Cytology (LBC) Specimen Diluent Tubes ThinPrep® PreservCyt® Solution |
Reagent/consumable capacity | BD COR™ GX Instrument: 180 HPV tests; 1,056 tips (11 tip trays) BD COR™ PX Instrument: 35 racks; 192 tips (2 trays; buffer) |
Waste capacity | Solid: 960 conversions (24 hours) Liquid: 2,160 tests (3 days) |
*Capacity and throughput may vary based on specimen types.
The BD COR™ System revolutionizes women's health and infectious disease diagnostics, addressing critical clinical gaps with cutting-edge automation. The Women's Health assays on the BD COR™ System represent years of meticulous research and development, showcasing exceptional clinical precision and reliability. Click here Take a deep dive to learn more about BD Women's Health Assays and how we are partnering with laboratories and providers to shape the future of Women’s Health.
BD Onclarity™ HPV Assay for BD COR™ System
The BD Onclarity™ HPV Assay was the first FDA-approved HPV assay offering extended genotyping. It can be run using both BD SurePath™ Liquid-based Pap Test or Hologic ThinPrep® Pap Test. This innovative technology propels your laboratory to the cutting edge in cervical cancer screening, empowering you to deliver comprehensive and actionable information to clinicians for more precise patient care. Uncover more about how the BD Onclarity™ HPV assay can give you the most comprehensive HPV results on the market today that individually identifies 6 genotypes
The BD CTGCTV2 assay is seamlessly integrated with BD Molecular and BD Urine specimen collection and transport devices for male and female urine, vaginal, endocervical swabs, and liquid-based cytology specimens on the Hologic ThinPrep® Pap Test. The assay is also indicated for use with asymptomatic and symptomatic individuals to aid in the diagnosis of chlamydial urogenital disease, gonococcal urogenital disease and/or trichomoniasis. Explore the possibilities of testing trichomoniasis at the same time as GT/GC on the BD CTGCTV2 assay.
BD Vaginal Panel for
BD COR™ System
The BD Vaginal Panel is a comprehensive diagnostic test that directly detects the three most common infectious causes of vaginitis – bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and Trichomonas vaginalis (TV) – in one test, using a single swab. This panel is specifically designed to help eliminate ambiguity in test results by providing clear positive or negative outcomes for each condition. Additionally, it delivers separate outcomes for Candida glabrata and C. krusei, two Candida species known for their resistance to conventional antibiotics. Find out more about how BD Vaginal Panel assay is shaping the future of Women's Health.
BD Vaginal Panel and BD CTGCTV2 for BD COR™ System
BD Vaginal Panel and BD CT/GC/TV2 for BD COR™ System can use the same sample to test for vaginitis and the 3 most common non-viral STIs in symptomatic women. 1 Sample, 5 Conditions, 7 Results. Explore more about how BD Vaginal Panel and BD CTGCTV2 can be used together to help shape the future of Women's Health.
BD Technical Services is your partner for performance. BD Service teams enable you to better serve your customers and patients. You can count on our deep knowledge and experience to help ensure your BD COR™ System delivers expected, timely results.
BD Service teams enable you to better serve your customers, patients and research partners. You can count on our deep knowledge and experience to help ensure your instruments deliver expected, timely results.
Remote Support Services (RSS) is the BD enterprise-class solution offering remote management and support of BD products deployed at your clinical and research laboratory.